Tiziana Life Financials

TLSA Stock  USD 0.73  0.05  7.35%   
Based on the measurements of operating efficiency obtained from Tiziana Life's historical financial statements, Tiziana Life Sciences is not in a good financial situation at this time. It has a very high odds of going through financial crisis in February. At present, Tiziana Life's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 7.9 M, whereas Total Assets are forecasted to decline to about 10.8 M. Key indicators impacting Tiziana Life's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio8.317.91
Sufficiently Up
Slightly volatile
The essential information of the day-to-day investment outlook for Tiziana Life includes many different criteria found on its balance sheet. An individual investor should monitor Tiziana Life's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Tiziana Life.

Net Income

(15.13 Million)

  
Please note, the presentation of Tiziana Life's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Tiziana Life's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Tiziana Life's management manipulating its earnings.

Tiziana Life Stock Summary

Tiziana Life competes with Clearmind Medicine, Coeptis Therapeutics, Quoin Pharmaceuticals, Affimed NV, and Leap Therapeutics. Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company was incorporated in 1998 and is headquatered in London, the United Kingdom. Tiziana Life is traded on NASDAQ Exchange in the United States.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINBMG889121031
CUSIPG88912103 88875G101
LocationUnited Kingdom
Business Address1415 Conduit Street,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.tizianalifesciences.com
Phone44 20 7495 2379
CurrencyUSD - US Dollar

Tiziana Life Key Financial Ratios

Tiziana Life Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets70.7M48.8M26.5M12.2M14.0M10.8M
Other Current Liab4.6M3.1M1.6M2.3M2.6M2.7M
Net Debt(65.3M)(42.2M)(17.8M)(936K)(842.4K)(884.5K)
Retained Earnings(84.6M)(108.1M)(116.3M)(133.7M)(120.3M)(114.3M)
Accounts Payable3.4M4.4M5.0M4.1M4.8M5.0M
Cash65.8M42.2M18.1M1.2M1.4M1.3M
Other Current Assets570.3K1.2M300K102K117.3K111.4K
Total Liab8.3M7.5M6.9M6.6M7.6M8.0M
Total Current Assets70.2M48.7M24.3M7.3M8.4M9.0M
Common Stock4.1M97K102K103K92.7K88.1K
Short Term Debt195K1.4M122K138K158.7K282.9K
Net Receivables3.8M5.3M5.9M6.1M7.0M7.3M
Inventory(1.3M)(2.3K)(5.3M)(6.0M)(5.4M)(5.1M)
Net Tangible Assets(5.5M)62.4M41.2M19.6M22.5M16.9M
Net Invested Capital62.4M41.3M19.6M5.5M6.4M6.0M
Net Working Capital62.2M41.1M17.6M798K917.7K871.8K

Tiziana Life Key Income Statement Accounts

202020212022202320242025 (projected)
Operating Income(28.0M)(27.4M)(14.6M)(18.0M)(16.2M)(15.4M)
Ebit(28.0M)(26.5M)(15.4M)(17.2M)(15.5M)(14.7M)
Ebitda(27.9M)(26.3M)(15.3M)(17.1M)(15.4M)(14.7M)
Income Before Tax(28.3M)(26.7M)(15.4M)(17.2M)(15.5M)(14.7M)
Net Income(26.1M)(23.4M)(15.4M)(17.7M)(15.9M)(15.1M)
Income Tax Expense(2.2M)(3.2M)811K449K404.1K424.3K
Interest Expense320K176K7K10K11.5K10.9K
Research Development6.0M13.2M13.0M8.1M9.3M9.8M
Gross Profit(250.0K)(89.8K)(141K)(51K)(45.9K)(43.6K)
Cost Of Revenue250.0K89.8K141K51K45.9K63.6K
Tax Provision(2.2M)(3.2M)0.0449K404.1K424.3K
Interest Income1K8K0.01.2M1.3M1.4M
Net Interest Income(312K)(176K)(7K)1.1M1.3M1.4M

Tiziana Life Key Cash Accounts

202020212022202320242025 (projected)
Change In Cash65.6M(23.6M)(24.1M)(16.9M)(15.2M)(14.5M)
Free Cash Flow(11.3M)(21.8M)(19.6M)(15.7M)(14.1M)(13.4M)
Depreciation91K141K51K96K110.4K147.1K
Other Non Cash Items9.9M354K(1.7M)1.3M1.5M1.6M
Net Income(26.1M)(26.7M)(15.4M)(17.2M)(15.5M)(14.7M)
End Period Cash Flow65.8M42.2M18.1M1.2M1.4M1.3M
Investments(123K)130K(4.0M)(1.3M)(1.4M)(1.5M)
Change To Netincome2.0M15M2.3M(3.1M)(3.6M)(3.4M)

Tiziana Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Tiziana Life's current stock value. Our valuation model uses many indicators to compare Tiziana Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tiziana Life competition to find correlations between indicators driving Tiziana Life's intrinsic value. More Info.
Tiziana Life Sciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Tiziana Life's Return On Equity is projected to drop slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Tiziana Life's earnings, one of the primary drivers of an investment's value.

Tiziana Life Sciences Systematic Risk

Tiziana Life's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Tiziana Life volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Tiziana Life Sciences correlated with the market. If Beta is less than 0 Tiziana Life generally moves in the opposite direction as compared to the market. If Tiziana Life Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Tiziana Life Sciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Tiziana Life is generally in the same direction as the market. If Beta > 1 Tiziana Life moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Tiziana Life Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Tiziana Life's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Tiziana Life growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.0102)

At present, Tiziana Life's Price Earnings To Growth Ratio is projected to drop slightly based on the last few years of reporting.

Tiziana Life January 4, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Tiziana Life help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Tiziana Life Sciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Tiziana Life Sciences based on widely used predictive technical indicators. In general, we focus on analyzing Tiziana Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Tiziana Life's daily price indicators and compare them against related drivers.

Complementary Tools for Tiziana Stock analysis

When running Tiziana Life's price analysis, check to measure Tiziana Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tiziana Life is operating at the current time. Most of Tiziana Life's value examination focuses on studying past and present price action to predict the probability of Tiziana Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tiziana Life's price. Additionally, you may evaluate how the addition of Tiziana Life to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk